Narrative review / 2007
A review suggests alternate-day fasting may modulate chronic disease risk factors, potentially to an extent similar to calorie restriction.
This review summarizes animal and human evidence regarding alternate-day fasting (ADF) and chronic disease risk compared with calorie restriction (CR). In humans, limited trials reported greater insulin-mediated glucose uptake, higher HDL-cholesterol concentrations, and lower triacylglycerol concentrations, but no effect on fasting glucose, insulin concentrations, or blood pressure, with no human cancer data to date. In animal studies, ADF lowered diabetes incidence, fasting glucose, insulin, total cholesterol, triacylglycerols, heart rate, and blood pressure, improved response to myocardial infarction, and showed decreases in lymphoma incidence, longer survival after tumor inoculation, and lower cell proliferation rates. The authors note that more research is required to establish definitively the consequences of ADF.
- Study type
- Narrative review of human and animal trials
- Who was studied
- Humans and animals across multiple reviewed studies (numbers not stated)
- What was measured
- Risk factors for type 2 diabetes, cardiovascular disease, and cancer
THE PAPER
Alternate-day fasting and chronic disease prevention: a review of human and animal trials.
Varady KA, Hellerstein MK. Am J Clin Nutr, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.